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Abstract
When the adenoviral protein E1B55K binds death domain-associated protein (Daxx), the proteasome-dependent
degradation of Daxx is initiated, and adenoviral replication is effectively maintained. Here, we show that the cellular
levels of Daxx differ between human and mouse cancer cell lines. Speciﬁcally, we observed higher cellular Daxx levels
and the diminished replication of oncolytic adenovirus in mouse cancer cell lines, suggesting that cellular Daxx levels
limit the replication of oncolytic adenoviruses that lack E1B55K in murine cells. Indeed, the replication of oncolytic
adenoviruses that lack E1B55K was signiﬁcantly increased following infection with oncolytic adenovirus expressing
Daxx-speciﬁc shRNA. Cellular Daxx levels were decreased in mouse cells expressing heat shock protein 25 (HSP25;
homolog of human HSP27) following heat shock or stable transfection with HSP25-bearing plasmids. Furthermore,
Daxx expression in murine cell lines was primarily regulated at the transcriptional level via HSP25-mediated inhibition
of the nuclear translocation of the signal transducer and activator of transcription 3 (stat3) protein, which typically
upregulates Daxx transcription. Conversely, human HSP27 enhanced stat3 activity to increase Daxx transcription.
Interestingly, human Daxx, but not mouse Daxx, was degraded as normal by ubiquitin-dependent lysosomal
degradation; however, HSP27 downregulation induced the ubiquitin-independent proteasomal degradation of Daxx.
Introduction
Daxx is a multifunctional, ubiquitously expressed pro-
tein implicated in various critical cellular functions such
as transcriptional regulation, apoptosis, carcinogenesis,
and antiviral protection1. Originally, Daxx was thought to
function as a repressor or activator of gene transcription2;
however, Daxx has also been found to inﬂuence tran-
scriptional activity by interacting directly with other
nuclear transcriptional factors including E26
transformation-speciﬁc sequence 1 (ETS1), paired box
gene 3 (PAX3), paired box gene 5 (PAX5), androgen
receptor, p53 family proteins, SMAD family member 4
(SMAD4), and glucocorticoid receptor to act as a tran-
scriptional corepressor3. Daxx is also a CD95-binding
protein that activates c-Jun NH2-terminal kinase (JNK)
via directly binding to apoptotic signal-regulating kinase 1
(ASK1)4,5. Studies have also implicated Daxx in viral
replication6–11. We previously observed that silencing of
the Daxx gene increased oncolytic adenoviral replica-
tion11, which is consistent with the fact that effective
adenoviral replication is maintained only when the ade-
noviral protein E1B55K binds to Daxx and triggers its
proteasome-dependent degradation9,12. Daxx was shown
to repress adenoviral replication by binding to α tha-
lassemia/mental retardation syndrome X-linked (ATRX),
and replication was restored via mutations that abolished
the interaction of Daxx with ATRX10. The interaction
between Daxx and heat shock protein 27 (HSP27) was
© The Author(s) 2019
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Hye Jin Choi (choihj@yuhs.ac) or Jae J. Song (jjs109@yuhs.ac)
1Institute for Cancer Research, Yonsei University College of Medicine, Seoul,
Korea
2Department of Oncology, Afﬁliated Hospital of Yanbian University, Yanji, Jilin
Province, PR China
Full list of author information is available at the end of the article.
These authors contributed equally: Zhezhu Han, Yeonsoo Joo, Jihyun Lee


































conﬁrmed by two-hybrid screening and glutathione S-
transferase (GST) pull-down assays13,14. According to
Charette et al.13, the phosphorylated dimeric form of
HSP27, but not the unphosphorylated multimeric form of
HSP27, interacts with Daxx both in vitro and in vivo,
thereby preventing (a) the association of Daxx with FS-7-
associated surface antigen (FAS) and ASK1 and (b) the
induction of apoptosis by Daxx coexpressed with ASK1.
In addition, Daxx interacts with the promyelocytic leu-
kemia (PML) protein15 and the transcription factors p53,
ETS1, PAX3, NF-κB, and E2F116; however, the precise
function of Daxx in cell death is controversial because
conﬂicting results have been obtained from transient
overexpression and gene knockout studies17.
The molecular chaperone HSP27 is a key regulator of
protein folding and degradation in human cells18. Typi-
cally, HSP27 expression is very low; however, various
stressful conditions such as heat shock, oxidative stress,
inﬂammation, and exposure to cytotoxic agents or
radiotherapy induce the massive accumulation of
HSP2719,20. The stable overexpression of HSP27 has been
observed in several human cancers, and high levels of
HSP27 are associated with aggressive tumor phenotypes
and poor prognosis19. Murine HSP25, which has biolo-
gical functions similar to those of its human homolog,
HSP2721, mediates the interaction between sirtuin 1
(SIRT1) and p53 and increases the deacetylation of p53,
consequently decreasing apoptosis22.
In this study, we demonstrate that adenoviral replica-
tion in mouse cancer cells increases after Daxx down-
regulation or HSP25 induction by mechanisms different
from those in human cancer cells.
Materials and methods
Cell lines and cell culture
Various human cancer cell lines (DU145, A375, Mia-
PaCa-2, HPAC, Huh7, Hep3B, MDAMB-231, and U251N
cells) in addition to 293 A cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) with 10% fetal
bovine serum (HyClone, Logan, UT, USA). Various
mouse cancer cell lines (4T1, Panc02 and BNL 1ME A.7
R.1 cells) in addition to NIH3T3 cells were also cultured
in DMEM with 10% fetal bovine serum, with the excep-
tion of B16BL6 cells, which were cultured in minimum
essential medium (MEM). BNL 1ME A.7 R.1 (BNL) cells
derived from BALB/c mice were kindly provided by Dr.
M.L. Chen (National Taiwan University, Taiwan). Panc02
cells were kindly provided by Dr. N. Mayorek (The
Hebrew University, Israel). All cells were maintained at
37 °C in a humidiﬁed atmosphere containing 5% CO2. To
develop a stable BNL-CAR cell line, BNL cells were
infected with retroviral LNCX-CAR. The infected cells
were selected by using G418 (2 mg/ml). To generate a
recombinant retrovirus based on LNCX, the Plat-A
retrovirus packaging cell line (Cell Biolabs, Inc., San
Diego, CA, USA), an amphotropic packaging cell line, was
transfected with LNCX-CAR. LNCX-CAR was con-
structed by incorporating HindIII/ClaI-digested CAR
after its production by PCR using pcDNA3.1hygro-CAR
as the template. The construction of pcDNA3.1hygro-
CAR was described in detail by Kang et al.23. LNCX-
E1B55K was constructed by incorporating HpaI/ClaI-
digested E1B55K after its production by PCR using
pcDNA3.1hygro-E1B55K, which was also described in
detail by Kang et al.23. A stable B16BL6 cell line expres-
sing CAR was selected by using puromycin (1 μg/ml), and
CAR expression was conﬁrmed after infection with ret-
rovirus produced by transfecting pMXs-puro-CAR into
the Plat-A packaging cell line. pMXs-puro-CAR was
constructed by incorporating the CAR gene into BamHI-
blunt-XhoI-digested pMXs-puro after the digestion of
pcDNA3.1hygro-CAR with HindIII-blunt-XhoI. To
establish B16BL6-CAR-E1B55K cells, B16BL6-CAR cells
were infected with retroviral LNCX-E1B55K and selected
by using G418 (2 mg/ml). A stable Panc02 cell line
expressing myrAkt was selected by using puromycin
(1.5 μg/ml), and myrAkt expression was conﬁrmed after
infection with retrovirus produced by transfecting pBabe-
puro-myrAkt into the Plat-A packaging cell line. The
BNL-HSP25, B16BL6-HSP25 and Panc02-HSP25 cell
lines were obtained by transfection of the BNL, B16BL6,
and Panc02 cell lines, respectively, with pcDNA3.1hygro-
HSP25 and selected with hygromycin (250 μg/ml).
Construction of Daxx-speciﬁc shRNAs
To construct human Daxx-speciﬁc shRNA, we screened
ﬁve candidate sequences. Target selection was performed
using an algorithm developed by Genolution Pharma-
ceuticals, Inc. (Seoul, South Korea). The selected target
sequence was 5′-GCTACAAGCTGGAGAATGAGAA
GCT-3′, and the loop sequence was 5′-TCTC-3′. To
express human Daxx-speciﬁc shRNA in adenovirus, the
top strand (5′-GATCCGCTACAAGCTGGAGAATGAG
AAGCTTCTCAGCTTCTCATTCTCCAGCTTGTAGC
TTTTTTA-3′) and the bottom strand (5′-AGCTTA
AAAAA GCTACAAGCTGGAGAATGAGAAGCTGAG
AAGCTTCTCATTCTCCAGCTTGTAGC G-3′) were
annealed and subcloned into BamHI/HindIII-digested
pSP72ΔE3-H1- shhTGFβ2. Mouse Daxx-speciﬁc shRNA
was constructed in a similar manner; the target sequence
was 5′-GTTAGGAAACAGCTATATAAAAGAA-3′, and
the loop sequence was 5′-TCTC-3′. To express mouse
Daxx-speciﬁc shRNA in adenovirus, the top strand (5′-G
ATCCGTTAGGAAACAGCTATATAAAAGAATCTCTT
CTTTTATATAGCTGTTTCCTAACTTTTTTA-3′) and
the bottom strand (5′-AGCTTAAAAAAGTTAGGAAAC
AGCTATATAAAAGAAGAGATTCTTTTATATAGCTG
TTTCCTAACG-3′) were annealed and subcloned into
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BamHI/HindIII-digested pSP72ΔE3-U6-shNC (negative
control) to yield pSP72ΔE3/U6-shmDaxx.
Cloning of mouse HSP25
HSP25-expressing pcDNA3.1hygro was constructed for
stable transfection into mouse liver cells or mouse mela-
noma cells. To clone mouse HSP25, RNA was extracted
from BNL cells after heat shock at 43 °C for 4 h, followed
by incubation at 37 °C for 24 h. HSP25 cDNA was gen-
erated via reverse transcription using reverse transcriptase
and subsequent PCR using the following primers: sense
primer, 5′-CGCGGATCCATGACCGAGCGCCGCGTG
CC-3′, and antisense primer, 5′-CCGCTCGAGCTAC
TTGGCTCCAGACTGTT-3′. The BamHI/XhoI-digested
PCR product was inserted into BamHI/XhoI-digested
pcDNA3.1hygro to yield pcDNA3.1hygro-HSP25.
Recombinant oncolytic adenovirus expressing human or
mouse Daxx-speciﬁc shRNAs
To express human Daxx-speciﬁc shRNA by oncolytic
adenovirus, the adenoviral shuttle vector pSP72ΔE3-H1-
shhDaxx was linearized by XmnI. The adenoviral backbone
vector dl324-BstBI was linearized by SpeI. The two linear-
ized vectors were cotransformed into E. coli BJ5183 cells for
the ﬁrst homologous recombination. The resultant dl324-
BstBI-H1-shhDaxx vector was linearized by Bsp1191, and
pVAX1-3484-CMV-ΔE1B, a shuttle vector with replication
competence, was linearized by PmeI. The construction of
pVAX1-3484-CMV-ΔE1B was described in detail by Kim
et al.24. The two linearized vectors were cotransformed into
E. coli BJ5183 cells for the second homologous recombi-
nation to yield dl324-3484-ΔE3-H1-shhDaxx (Ad-3484-
shhDaxx). To express mouse Daxx-speciﬁc shRNA from
oncolytic adenovirus, pSP72ΔE3-U6-shmDaxx was used as
a shuttle vector, and the process was repeated in the same
manner for human Daxx.
Construction of the 5′-ﬂanking region of the mouse Daxx
gene
We searched the mouse Daxx promoter region from
mouse genomic DNA originating from EBI Database
accession No. AF110520.1. First, the promoter region of
Daxx was sequenced using a primer (5′- GTCTCC
GTCTTACACAGTTC-3′) that binds near the N-terminal
Daxx coding sequence from BNL (or B16BL6) genomic
DNA and aligned with the human Daxx promoter
sequence provided by Li et al.25. As a result, a 659 bp
fragment in this region similar to the human Daxx pro-
moter region spanning from −659 to −1 was generated by
PCR using the following primers: forward, 5′- TGCT
GTGCTCATTTGTATGCG-3′, and reverse, 5′-CATAGT
TCCCTCCGCCTTCC-3′. For PCR, BNL genomic DNA
was used as a template. To conﬁrm the mouse Daxx
promoter sequence, the PCR product was subcloned into
T-vector pMD20 (TaKaRa, Japan), which has a dT over-
hang at the 3′ end, and sequenced (Fig. 5a).
Construction of Daxx promoter-luciferase reporter
plasmids
To construct mouse Daxx promoter-luciferase reporter
plasmids, a 659 bp fragment spanning from −659 to −1
was generated by PCR using the following primers: 5′-C
GGTGGTACCTGCTGTGCTCATTTGTATGC-3′ and
5′-ATCTAAGCTTTTCCTCTCCCCAACCCCCAC-3′,
which contain the KpnI and HindIII restriction enzyme
sites, respectively. PCR constructs were then subcloned
into the pGL3-basic luciferase vector (Promega, Madison,
WI, USA) at the KpnI and HindIII sites to produce a full
length Daxx-p 659 construct. Furthermore, to produce
putative Daxx promoter-luciferase constructs, a series of
5′-3′ or 3′-5′ Daxx-deleted promoter constructs, Daxx-p
479, 299, 159, 500, and 590, were generated by PCR using
their corresponding PCR primer pairs and then ligated
with the pGL3-basic vector. The Daxx-p 69 deletion
mutant construct was constructed after annealing the
following two strands and ligating them with the pGL3-
basic vector: 5′-CGTGCTCCAGGCGGAAGCGCTAA
GGCTTCCGGTCTGTTGTGGGGTCTGCGGTGGGGG
TTGGGGAGAGGAA-3′ and 5′- AGCTTTCCTCTC
CCCAACCCCCACCGCAGACCCCACAACAGACCGG
AAGCCTTAGCGCTTCCGCCTGGAGCACGGTAC-3′.
The mutant Daxx-p159 construct, in which one base in
the Sp1-binding site was mutated (GGGCGAG →
GGGCGGG), in the pUC57 vector was provided by
Bionics (Seoul, South Korea) and cloned into the pGL3-
basic vector.
Construction of stat3 promoter-luciferase reporter
plasmids
The mouse stat3 promoter sequence was provided by
Ichiba et al.26. To conﬁrm the stat3 promoter sequence in
the mouse BNL cell line, the stat3 promoter region was
obtained from BNL cell genomic DNA by PCR using the
following primers: 5′-TTAAGTGGGGTGACACCTG
GG-3′ and 5′- CAGGTTCCCCCTCCCTGTCTA-3′. The
resultant PCR product from −476 to 62 bp was subcloned
into the pMD20-T vector and sequenced. The sequence
of the PCR product is provided in Supplementary Fig. 2.
For the luciferase assay, this PCR product in the pMD20-
T vector was subcloned into the pGL3-basic luciferase
vector at the KpnI and HindIII sites to produce a mouse
stat3 promoter construct.
Chromatin immunoprecipitation (ChIP) assay
A CHIP assay was performed to analyze the ability of
the stat3 protein to bind the Daxx promoter using a Pierce
Magnetic ChIP kit (Thermo Scientiﬁc, Rockford, IL, USA)
according to the manufacturer’s instructions. The
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following primer pairs were used to amplify the Daxx core
promoter (−161 to −1):
Human Daxx ChIp assay primer
● Forward: TGAAATCCCCACCACTTCCTCCCTC
● Reverse: GAGAGGCAGTGTTTTCAGCATTTGT
Mouse Daxx ChIp assay primer
● Forward: CAGGTGCACACACACACGAACACAC
● Reverse: CATAGTTCCCTCCGCCTTCCTCTCC
Construction of various HSP25 proteins substituted with
the HSP27 domain
The 2 most variable amino acid regions of HSP25
compared to those of HSP27 were substituted with the
corresponding HSP27 amino acids. The 1st region was
amino acids 47–51 of HSP25 (FSAAG), which was sub-
stituted with amino acids 46–50 of HSP27 (LGGSS). To
change the amino acids in box I, the DNA sequence was
changed from ttcagcgccgctggg (FSAAG) to ttaggcggcag-
cagc (LGGSS). To substitute box I of HSP25 with the
corresponding sequence of HSP27, the 5′-HindIII to 3′-
SacI HSP25 fragment containing HSP27 ttaggcggcagcagc
(LGGSS), which originated from pUC57-chimeric HSP25,
was inserted into HindIII/SacI-digested pcDNA3.1hygro-
HSP25. To produce various substituted HSP25 proteins,
the SacI site in the CMV promoter of pcDNA3.1 was
deleted by site-directed mutagenesis with sense primer
(5′-TATATAAGCAGAGCTGTCTGGCTAACTAGAG-
3′) and antisense primer (5′-CTCTAGTTAGCCAG
ACAGCTCTGCTTATATA-3′). To produce pcDNA3.1-
hygro-HSP25 without HindIII at the multicloning site,
BamHI-blunt/XhoI-digested HSP25 was inserted into
NheI-blunt/XhoI-digested pcDNA3.1hygro. Box II, which
consisted of amino acids 61–72 of HSP25 (AATAEG-
PAAVTL), was substituted with amino acids 60-68 of
HSP27 (PAAIESPAV). To substitute box II of HSP25 with
the corresponding HSP27 sequence, a 5′-HindIII to 3′-SacI
HSP25 fragment containing HSP27 cccgccgccatcga-
gagccccgcagtg (PAAIESPAV), which originated from
pUC57-chimeric HSP25, was inserted into HindIII/SacI-
digested pcDNA3.1hygro-HSP25. To substitute both box I
and box II of HSP25 with the corresponding
HSP27 sequences, a 5′-HindIII to 3′-SacI HSP25 fragment
containing box I of HSP27, ttaggcggcagcagc (LGGSS), and
box II of HSP27, cccgccgccatcgagagccccgcagtg (PAAIE-
SPAV), which originated from pUC57-chimeric HSP25,
was inserted into HindIII/SacI-digested pcDNA3.1hygro-
HSP25.
Animal studies
The animal protocol (2016-0014) used in this study was
reviewed and approved by the Institutional Animal Care
and Use Committee of the Yonsei University Health
System. To generate a xenograft tumor model, 6 × 106
MiaPaCa-2 cells or 1 × 107 Panc02-myrAkt cells were
injected with Corning Matrigel Matrix (Corning, Corning,
NY, USA) into the subcutaneous abdominal regions of
male BALB/c nude mice or C57BL/6 mice, respectively.
The Panc02-myrAkt cells injected in the mice were a pool
of selected clones (#2, #5, #7, #9, #10) (Supplementary Fig.
8). When the tumors derived from MiaPaCa-2 cell or
Panc02-myrAkt cell reached an average size of
50–60 mm3 or 80–100 mm3, respectively, the mice were
randomized into three groups (PBS, Ad-3484-shNC, Ad-
3484-shDaxx) of 5 mice each. The oncolytic adenoviruses
used were oncolytic negative control (NC) adenovirus
(Ad-3484-shNC) and human or mouse Daxx-speciﬁc
shRNA-expressing oncolytic adenovirus (Ad-3484-
shDaxx). The mice in each group received intratumoral
injections of 1 × 109 plaque forming units (pfu) of one of
the two oncolytic adenoviruses diluted in 50 μl of PBS or
PBS alone. Intratumoral injections were repeated every
other day for a total of three injections. Tumor growth
was measured using a caliper every 2 days for 15 days
until necrotic cell death was observed. Tumor volume (V)
was calculated using the following formula: V (mm3)=
0.52 × length (mm) × width (mm)2.
Immunohistochemistry
Seven days after the subcutaneous injection of MiaPaCa-2
or Panc02-myrAkt cells into the abdominal regions of male
BALB/c nude mice or C57BL/6 mice, respectively, one of
two oncolytic adenoviruses (Ad-3484-shNC or Ad-3484-
shDaxx, 1 × 109 pfu/50 μl) was intratumorally injected every
other day for a total of three injections. Seven days after the
last viral injection, tumor tissues were extracted, ﬁxed for
24 h in 10% formaldehyde, and parafﬁn embedded for
immunohistochemical (IHC) staining.
Statistical analyses
Data are presented as the mean ± standard error of the
mean (S.E.M.). Differences between groups were exam-
ined using unpaired two-tailed t-tests. P values were cal-
culated using GraphPad Prism version 6.0. P < 0.01 or P <
0.05 indicated statistical signiﬁcance. All experiments
were performed three times independently.
Results
Silencing of Daxx in murine and p53-mutant human cancer
cells increases adenoviral replication
Adenoviral replication is effectively maintained only
when the adenoviral E1B55K protein binds to Daxx and
induces its proteasome-dependent degradation9. Pre-
viously, we showed that Daxx downregulation enhanced
adenoviral replication11. In this study, we examined cel-
lular Daxx levels in various human and mouse cancer cell
lines. Interestingly, cellular Daxx levels were higher in all
examined mouse cancer cell lines than in all examined
human cancer cell lines (Fig. 1a). Therefore, we
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Fig. 1 (See legend on next page.)
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speculated that low adenoviral replication in mouse cells
is caused by increased cellular levels of Daxx, which
represses adenoviral replication11,12. We then examined
adenoviral infectivity in mouse and human cancer cells.
The mouse cancer cell lines examined, except Panc02
cells, showed very low infectivity (Fig. 1b, Supplementary
Fig. 1). However, although infectivity in B16BL6, B16F10
or BNL mouse cancer cells increased to a level similar to
that in human cancer cells with the introduction of cox-
sackievirus and adenovirus receptor (CAR) (Supplemen-
tary Fig. 2), viral production in B16BL6-CAR, B16F10-
CAR, BNL-CAR, and Panc02 cells was at least 10-fold
lower than that in DU-145 and MiaPaCa-2 cells (Fig. 1c).
Downregulation of cellular Daxx in mouse cancer cell
lines (B16BL6-CAR, B16F10-CAR, BNL-CAR, and
Panc02 cells) and p53-mutant human cancer cell lines
(MiaPaCa-2 and DU145 cells) by infection with Daxx-
speciﬁc shRNA-expressing oncolytic adenovirus increased
adenoviral replication (Fig. 1c). In contrast, the replication
of Daxx-speciﬁc shRNA-expressing oncolytic adenovirus
was not increased in human cancer cell lines expressing
wild-type p53 (HPAC and A375 cells; Fig. 1c). In BNL
cells with very low adenoviral infectivity, the introduction
of CAR-expressing retrovirus increased infectivity by
more than 5-fold (Fig. 1d). E1B55K expression in the form
of replication-competent adenovirus (RCA) did not sig-
niﬁcantly increase viral production compared to that
observed with Daxx-shRNA expression in the oncolytic
adenovirus without E1B55K (Fig. 1e). In fact, E1B55K in
the RCA decreased Daxx levels to a lesser extent than the
expression of Daxx-shRNA in the adenovirus (Fig. 1fa),
and additional Daxx downregulation with RCA sig-
niﬁcantly increased viral production (Fig. 1fb), which
suggests that Daxx downregulation plays a critical role in
enhancing viral production in even E1B55K-containing
oncolytic adenovirus. This ﬁnding provides a strong
impetus to utilize oncolytic adenoviruses with reduced
Daxx expression regardless of E1B55K expression. Fur-
thermore, decreased cellular Daxx expression increased
oncolytic activity in both mouse and mutant p53-
harboring human cancer cell lines (Fig. 1g), which was
similar to the pattern of virus production observed in
murine cancer cell lines (Fig. 1c).
Mechanisms by which the proteasomal degradation of
Daxx is regulated differ between human and murine
cancer cells
The importance of p53 status for viral replication in
human and mouse cells was further investigated by intro-
ducing mutant p53 into human and mouse cancer cells that
harbor endogenous wild-type p53. Unlike the increase in
viral production observed after the introduction of mutant
p53 in human cells with wild-type p53, the introduction of
mutant p53 into mouse cancer cell lines with wild-type p53
did not increase viral replication. In contrast, Daxx down-
regulation increased viral production in mice irrespective of
p53 status or cell type (Supplementary Fig. 3). To better
understand why the murine cancer cell lines expressed
higher levels of Daxx at resting state than the human cancer
cell lines, we examined the expression levels of HSP27 and
its murine homolog, HSP25, in the human and murine
cancer cell lines, respectively, because HSP27 has been
previously shown to be a common binding partner of both
p53 and Daxx in human cells27. First, interactions between
these HSPs and p53/Daxx in our cell lines were veriﬁed
using coimmunoprecipitation assays (Fig. 2a, left). The
(see ﬁgure on previous page)
Fig. 1 Enhanced adenoviral replication by silencing Daxx in mice. a Cellular Daxx levels in human cancer cell lines (left), mouse cancer cell lines
and two human cancer cell lines used as controls (right) were examined by immunoblotting. b Adenoviral infectivity of various mouse and human
cancer cell lines was examined using replication-incompetent GFP-expressing adenovirus after 48 h of infection (multiplicity of infection [MOI] of 20;
×100 magniﬁcation). c Adenoviral replication was enhanced by Daxx downregulation in mouse or p53-mutant human cancer cell lines using Daxx-
speciﬁc shRNA-expressing oncolytic adenovirus at an MOI of 100 for 48 h. Panc02 and B16F10-CAR cells were infected at an MOI of 200 for maximal
infectivity. The same number of all cancer cell lines (1 × 105 cells) were plated onto 6-well plates and infected with Ad-3484-NC or Ad-3484-shDaxx at
an MOI of 100 or 200 for maximal infectivity. After 48 h of infection, each viral soup (3 ml) was titrated after repetitive freeze-thaw cycles. Ad-3484-
shhDaxx (shhDaxx, shRNA targeting human Daxx), Ad-3484-shmDaxx (shmDaxx, shRNA targeting mouse Daxx), and Ad-3484-NC (NC, negative
control, the scrambled DNA sequence of the shRNA). Ad-3484-NC adenovirus is a replication-competent adenovirus used as a negative control, and
3484 indicates the presence of E1A in the viral genome controlled by the cytomegalovirus (CMV) promoter lacking the E1B region. Error bars
represent standard errors from three independent experiments. d BNL mouse cell lines were infected with LNCX-CAR, and a clone expressing CAR
was selected for efﬁcient adenoviral replication in mouse cell lines (left). Enhanced adenoviral infection was observed in clone #1 of BNL-CAR after
infection with replication-incompetent GFP-expressing adenovirus at an MOI of 20 for 48 h (right, 100 ×magniﬁcation). e Cellular Daxx levels were
examined in B16BL6 cells, CAR-expressing B16BL6 cells (B16BL6-CAR) and B16BL6 cells expressing both CAR and E1B55K (B16BL6-CAR-E1B55K) by
immunoblotting. f Cellular Daxx levels and viral production were examined after infection with oncolytic adenovirus expressing shRNA targeting
mouse Daxx without E1B55K and/or RCA expressing E1B55K at an MOI of 50 or 100 for 48 h. g To compare the oncolytic activity induced by Ad-3484-
NC with that induced by Ad-3484-shhDaxx or Ad-3484-shmDaxx, human and mouse cancer cell lines were infected with each virus at an MOI
between 0.1 and 50. Immediately after 293 A cells infected with one of the viruses at an MOI of 0.1 exhibited complete cell lysis, all remaining cells on
the plate were ﬁxed with 4% paraformaldehyde and stained with 0.5% crystal violet (upper). Cell viability after infection with each virus was
compared by cell death curves in a quantitative graph (lower). Error bars in a, c, e, and g represent standard errors from three independent
experiments
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interaction between p53 and HSP27 was observed in
human cancer cells; however, unexpectedly, HSP25 was not
detected in any of the examined mouse cancer cell lines
(data not shown), and no interaction between p53 and
HSP25 was found (Fig. 2a, right). Similar results were also
observed for the interactions between Daxx and HSP27 or
HSP25 (Fig. 2b, left, right). In addition, HSP27 interacted
with the transcription factors ETS1 and Sp1, but HSP25 did
not interact with ETS1 and Sp1 (Fig. 2c). Interestingly,
cellular Daxx levels were markedly decreased upon the
introduction of HSP25 into mouse cancer cells (Fig. 2d). In
contrast, HSP27 downregulation in various human cancer
cell lines decreased Daxx expression in a dose-dependent
























































Fig. 2 (See legend on next page.)
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downregulation in human cancer cells was at least in part
due to the proteasomal degradation of Daxx (Fig. 2f, left); in
contrast, the decrease in Daxx levels in mouse BNL cells
overexpressing HSP25 was not related to proteasomal
degradation (Fig. 2f, right). The mechanisms by which Daxx
undergoes proteasomal degradation after HSP27 down-
regulation were further evaluated by analyzing the ubiqui-
tination of Daxx in human MiaPaCa-2 cells. Unexpectedly,
however, an increase in ubiquitinated Daxx was not
observed upon HSP27 downregulation (Fig. 2g). Accord-
ingly, the downregulation of ubiquitin by siRNA did not
lead to a further reduction in Daxx protein levels with
HSP27 shRNA treatment (Fig. 2h). Thus, the proteasomal
degradation of Daxx induced by HSP27 downregulation is
ubiquitin-independent. Meanwhile, treatment with siRNA
targeting ubiquitin enhanced the basal level of Daxx in
control Adeno-shNC-infected cells (Fig. 2h), and this
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lysosomal degradation was inhibited by chloroquine treat-
ment (Fig. 2i). These ﬁndings indicate that Daxx degrada-
tion at the stationary phase occurs through a ubiquitin- and
lysosome-dependent mechanism. Taken together, these
data demonstrate that HSP27 functions as a molecular
chaperone to protect cellular Daxx from proteasomal
degradation in human cancer cells, but HSP25 does not
play a similar role in murine cancer cells, at least with
respect to mouse Daxx. Another possibility is that HSP25
functions as an inhibitor of Daxx transcription.
HSP25 localizes predominantly to the cytoplasm of murine
cells, where it impairs the nuclear localization of positive
regulator(s) of Daxx transcription
Although neither HSP25 nor HSP27 were detected in
mouse cancer cells, the cellular levels of Daxx were much
higher in mouse cells than in human cancer cells (Fig. 3a),
supporting the notion that HSP25 is not required as a
molecular chaperone to protect Daxx from degradation in
mouse cancer cells. Furthermore, cellular Daxx levels
decreased markedly after the heat shock induction of
HSP25 expression in these mouse cancer cells (Fig. 3b),
and transcriptional repression of Daxx was triggered by
the transcriptional induction of HSP25 in these cells,
suggesting that Daxx expression is inversely proportional
to HSP25 gene expression (Fig. 3c). Finally, adenoviral
replication in both B16BL6-CAR and BNL-CAR cells
increased markedly following HSP25 expression (Fig. 3d,
left). In contrast, adenoviral production increased upon
the downregulation of HSP27, especially in human cancer
cells with mutant p53 (Fig. 3d, right). Next, we demon-
strated that the decrease in Daxx levels following HSP27
downregulation in human cancer cells resulted from
decreased binding of ETS1 and SP1 to the Daxx promoter
(Fig. 3e, left, middle), whereas HSP25 downregulation in
murine cells increased ETS1 binding to the Daxx pro-
moter (Fig. 3e, right). Taken together, these data led us to
hypothesize that most of the induced HSP25 was localized
in the cytoplasm and that HSP25 strongly inhibited the
nuclear translocation of positive regulator(s) of Daxx gene
expression. Unlike the arginine-rich nuclear localization
signal (NLS) of Drosophila HSP2728, neither human
HSP27 nor mouse HSP25 has an arginine-rich NLS.
Therefore, we sought out potential NLSs and used the
PSORT program to predict subcellular protein localiza-
tion sites. HSP27 was predicted to localize to the nuclei
(39.1%), cytoplasm (47.8%) and mitochondria (13.0) of
human cells; in contrast, HSP25 was predicted to localize
mainly outside the nucleus (77.8%), with only 22.2% of
HSP25 localizing within the nucleus. Thus, the proportion
of nuclear HSP25 is half that of HSP27. In fact, HSP25 in
mouse cells was primarily located in the cytoplasm,
whereas HSP27 was ubiquitously expressed in both the
nucleus and cytoplasm (Fig. 3f, g). Thus, these ﬁndings
supported our hypothesis that HSP25 likely sequesters
positive regulator(s) of Daxx expression. We then exam-
ined whether the introduction of HSP27 into mouse cells
would provide a shuttle to move these putative Daxx
positive regulator(s) into the nucleus, leading to the
recovery of cellular Daxx levels. As shown in Fig. 3h,
cellular Daxx levels were signiﬁcantly upregulated by
HSP27 overexpression, which presumably enhanced the
nuclear localization of putative positive regulator(s) of
Daxx transcription.
Absence of the Sp1-binding site in the murine Daxx
promoter and identiﬁcation of the Daxx core promoter
region
Unlike the positive correlation observed between the
expression levels of Daxx and HSP27 in human cancer
(see ﬁgure on previous page)
Fig. 2 Comparison of proteasomal Daxx degradation in human and mouse cells. a Human A375 and MiaPaCa-2 cells and mouse B16BL6-HSP25
cells were lysed and subjected to immunoprecipitation with an anti‐p53 (left, right) or anti-HSP25 (right) antibody to detect the interaction between
p53 and HSP27 (or HSP25). b Human A375 and MiaPaCa-2 cells and mouse BNL-HSP25 cells were lysed and subjected to immunoprecipitation with
an anti‐HSP27 (or anti-HSP25) antibody to detect the interaction between HSP27 (or HSP25) and Daxx. c Human A375 and MiaPaCa-2 cells and
mouse BNL-HSP25 cells were lysed and subjected to immunoprecipitation with an anti‐p53 or anti-HSP27 (or anti-HSP25) antibody to detect the
interaction between p53 and Ets1/Sp1 or HSP27 (or HSP25) and Ets1/Sp1. d Cellular Daxx levels in various mouse cancer cell lines were examined
after the stable transfection of PancO2, B16BL6 and BNL cells with pcDNA3.1hygro-HSP25. e Validation of HSP27 downregulation-dependent Daxx
downregulation in human cancer cells after infection with defective adenovirus expressing shRNA against HSP27 at MOIs between 1 and 100. Then,
cellular Daxx and HSP27 levels in human cancer cells were detected by western blotting. f Cellular Daxx levels in human (MiaPcCa-2, A375) and
mouse (BNL) cancer cell lines treated with MG132 (10 µM, 4 h) after infection with defective adenovirus expressing shRNA against HSP27 (48 h) or
stably expressing HSP25 were examined. The numbers indicate the band intensity relative to that of Ad-NC (MiaPaCa-2, A375 cells) or control (BNL
cells) after band intensities were measured with a densitometer. g Human MiaPaCa-2 cells after infection with defective adenovirus expressing shRNA
targeting HSP27 at an MOI 100 treated with MG132 (10 µM, 4 h) were lysed and subjected to immunoprecipitation with an anti-Daxx antibody to
detect ubiquitin. h Human MiaPaCa-2 cells were transfected with NC siRNA (negative control, scrambled siRNA) or siRNA against ubiquitin, followed
by infection with defective adenovirus expressing NC shRNA NC or shRNA against HSP27 (MOI of 100, 48 h). Cellular levels of Daxx were examined to
determine whether HSP27 downregulation-mediated Daxx degradation is ubiquitin-dependent (upper), and cellular levels of ubiquitinated proteins
were detected (lower). The numbers indicate the band intensity relative to that of siNC/Ad-NC after band intensities were measured with a
densitometer. i MiaPaCa-2 cells were treated with chloroquine (30 µM, 6 h), and cellular levels of Daxx were examined
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cells, Daxx levels were much higher in mouse cancer cells
than in human cancer cells with concomitant undetect-
able levels of HSP25, as mentioned earlier (Figs. 1a, 2a).
To determine whether there are any signiﬁcant differ-
ences between the human and mouse Daxx promoters,
the Daxx promoter region was analyzed. We found that
the consensus Sp1 transcription factor-binding site was
absent in the mouse Daxx promoter (Fig. 4a, b, Supple-
mentary Fig. 7). Furthermore, cellular Daxx levels in
mouse cells did not change following Sp1 downregulation
(Fig. 4c), suggesting that Sp1 is not a critical driver of
transcription from the Daxx promoter. Next, we exam-
ined the involvement of the Sp1-binding site in the
human Daxx promoter in mouse cancer cells by changing
the adenine in the murine Daxx promoter to guanine to
mimic the human Sp1-binding sequence. The activity of
the mutated Daxx promoter was enhanced compared with
that of the wild-type core promoter in three different
mouse cell lines (Fig. 4d). These experiments revealed that
nucleotides −1 to −159 in the Daxx promoter region in
mouse cancer cells can provide core promoter activity
despite the lack of an Sp1-binding site.
Signal transducer and activator of transcription 3 (stat3)
acts as a positive regulator of Daxx expression
Next, we sought to identify binding partners of HSP25
and HSP27 that might function as transcription factors to
drive Daxx expression. According to Arrigo et al.27, the
transcription factor stat3 is a potential HSP27-binding
partner that also binds to the Daxx promoter29, as
reported in the “GeneCards” database. Coimmunopreci-
pitation assays showed that stat3 interacts with HSP25
and HSP27 in mouse and human cells, respectively
(Fig. 5a). Intriguingly, stat3 binding to the Daxx promoter
region was signiﬁcantly inhibited by HSP25 expression
(Fig. 5b); this observation raised the possibility that HSP25
interferes with the ability of stat3 to bind to and activate
transcription from the Daxx promoter, which stands in
contrast to the role of HSP27 in promoting stat3-
mediated Daxx transcription in human cells. This result
was further conﬁrmed by the observation of differential
stat3 localization in the nucleus and cytoplasm using
confocal microscopy and cellular fractionation (Fig. 5c, d).
As shown in Fig. 5d, both nuclear and cytosolic stat3
proteins in human cells were decreased by HSP27
downregulation (Fig. 5d, right), whereas most stat3 loca-
lized to the cytoplasm in mouse cells expressing HSP25
(Fig. 5d, left). Moreover, stat3 acted as a positive regulator
of Daxx expression in both mouse and human cells,
suggesting that cellular Daxx is also transcriptionally
controlled by stat3 (Fig. 5e). Taken together, our obser-
vations suggest two different ways by which cellular Daxx
levels in human and mouse cells are controlled; cellular
levels of Daxx regulated by HSP27 downregulation were
controlled by both proteasomal degradation and stat3-
dependent transcriptional induction, whereas in murine
cells, the regulation of Daxx levels by HSP25 resulted
mainly from stat3-dependent transcription.
HSP25 structural domain responsible for stat3
mobilization to the nucleus
To identify the domain(s) of HSP25 responsible for the
cytoplasmic localization of HSP25 and its inhibition of
stat3 nuclear translocation, various chimeric constructs of
HSP25 containing domains I, II, or I+ II of HSP27 were
constructed, and any changes in the localization of HSP25
and stat3 were examined (Fig. 6a). Domains I and II of
HSP25 and HSP27 are the most divergent regions
between these proteins; therefore, these regions of HSP27
were swapped for the corresponding regions of HSP25.
Both domains I and II of HSP27 were responsible for
mobilizing HSP25 to the nucleus (Fig. 6b) and mediating
the nuclear translocation of stat3 (Fig. 6c).
Unexpectedly, both cytosolic and nucleic levels of stat3
increased (rather than nuclear levels only) after the
introduction of HSP25/27 I+ II into the BNL mouse cell
(see ﬁgure on previous page)
Fig. 3 HSP25 is a cellular counterpart of adenoviral E1B55K in mice. a To investigate the correlation between Daxx and HSP27 (or HSP25),
cellular HSP27, HSP25, Daxx, and actin levels were examined by western blot analysis. b Cellular Daxx levels in various mouse cancer cell lines that
underwent heat shock induction of HSP25 were examined at 43 °C for 4 h followed by incubation at 37 °C for 24 h. c Cellular Daxx and HSP25 mRNA
levels were examined in various mouse cancer cells by real-time RT-PCR after heat shock at 43 °C for 4 h followed by incubation at 37 °C for 24 h. HS:
heat shock d Enhanced adenoviral replication was conﬁrmed in mouse cancer cells stably expressing HSP25 or human cancer cells in which HSP27
was downregulated. After infection of B16BL6-CAR or BNL-CAR cells stably expressing HSP25 with oncolytic adenovirus at an MOI of 100 (Ad-3484-
NC) for 48 h, viral production was estimated (left). After infection of human cancer cells with oncolytic adenovirus at an MOI of 100 (Ad-3484-NC or
Ad-3484-shHSP27) for 48 h, viral production was estimated (right). e Human MiaPaCa-2 and A375 cells and mouse BNL-CAR-HSP25 HPAC cells were
infected with defective adenovirus expressing shRNA against HSP27 (or HSP25) at an MOI of 100. After 48 h, Daxx promoter activity was analyzed by
Chip assays using antibodies against SP1 or Ets1. f The distribution of HSP27 or HSP25 was examined using confocal immunoﬂuorescence. Cellular
HSP27 or HSP25 was detected with species-speciﬁc primary anti-HSP27 or anti-HSP25 antibodies conjugated to Flamma 552 or Flamma 488,
respectively. g The cytoplasmic/nuclear localization of HSP27 or HSP25 was examined in the cytoplasm and nuclei of human a or mouse cancer cells
b after their fractionation using cytoplasmic (actin) and nuclear (histone H1) marker proteins, respectively. h Recovery of Daxx expression with the
introduction of HSP27 into mouse B16BL6 cells. Cellular Daxx levels were examined after B16BL6 cells were transfected with pcDNA3.1/HSP25 or
pcDNA3.1/HSP25+ pcDNA3.1/HSP27. Error bars in c, d, and e represent standard errors from three independent experiments
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GCGGAGCAGG CCGGTGCCGT ACGGCAACAT GGCGCGCCCC ATCTACCTGG TCCTCCGCCC 
CGCCCCGTCG AGCCTCCGCG TCCCCGGAGC GGTGGCCTCG GTGGGCGAGC CGAGCGTCAC 
TTCCGGCTCT AAGCGGCCTG GGTCCCGTAC AGCAATATGG CCGCCCTCAG GTGCTCCAGG 


















Fig. 4 Characterization of the Daxx (death domain associated protein) promoter region in mouse cell lines. a The nucleotide sequence of the
5’-UTR of the Daxx gene from BNL cells contains Ets1 (red) and deﬁcient Sp1 (blue) consensus sequences in the core promoter region (underlined).
The ﬁrst codon (bold, black) is indicated. b Schematic representation of Daxx promoter-luciferase reporter plasmids in mouse cells: Daxx-p659
containing the full-length promoter with a putative Ets1-binding site; Daxx-p479, Daxx-p299, Daxx-p159, Daxx-p69, Daxx-p500, and Daxx-p590
containing a series of 5’-3’ or 3’-5’ deleted promoters; Daxx-p159S, which is Sp1 site-recovered Daxx-p159 c Cellular levels of Daxx were examined
after transfection of A375 or BNL-HSP25 cells with siRNA against Sp1 or Ets1. d Transient transfection of various mouse cell lines and luciferase assays
to determine Daxx promoter activity. Cells were transfected with 1 μg of each Daxx promoter construct or the pGL3-basic vector, which served as a
negative control. Data represent the mean ± standard error of three independent experiments normalized to the activity of Renilla luciferase with the
CMV promoter (pRL) (cotransfection with pRL-CMV as an internal control). Error bars represent standard errors from three independent experiments
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line. To determine whether HSP25/27 protects STAT3
from proteolytic degradation, cellular levels of stat3 were
examined after the introduction of HSP25, HSP25/27
domains I+ II, or HSP27; interestingly, increased levels of
stat3 were found in BNL cells with HSP25/27 domains I
+ II or HSP27 (Fig. 6d). This hypothesis originated from
the results in Fig. 5a, which shows that the interaction
between HSP27 and stat3 was stronger than that between
HSP25 and stat3. We found no interaction between stat3
and HSP25/27 domains I+ II (Supplementary Fig. 5a);
instead, domains I and II appeared to contribute to
increasing the expression of stat3 (Supplementary Fig. 5b,
c).
Infection with oncolytic adenovirus expressing Daxx-
speciﬁc shRNA decreased tumor growth in two different
mouse models
After conﬁrming that Daxx was downregulated follow-
ing treatment with an oncolytic adenovirus expressing
Daxx-speciﬁc shRNA in vitro (Supplementary Fig. 4) and
that viral production was consequently increased (Fig. 1c),
we determined whether an oncolytic adenovirus expres-
sing Daxx-speciﬁc shRNA was able to enhance oncolysis
in vivo (Fig. 7). For this purpose, we generated BALB/c
nude mice harboring MiaPaCa-2 xenografts and C57BL/6
mice harboring Panc02-myrAkt syngeneic tumor grafts.
We then examined tumor growth inhibition following the
infection of each mouse model with oncolytic adeno-
viruses expressing Daxx-speciﬁc shRNA or negative
control (NC; PBS or NC-shRNA-expressing oncolytic
adenovirus). As expected, tumor growth inhibition was
proportional to Daxx downregulation in both human-
derived tumor xenografts (Fig. 7a) and mouse-derived
syngeneic tumor grafts (Fig. 7b), suggesting that Daxx
downregulation serves as a key strategy to enhance
oncolysis in murine tumors.
Discussion
A previous study indicated that E3 ubiquitin ligases
such as E1B55K may be responsible for Daxx degrada-
tion9,30. However, in our system, Daxx degradation
through its ubiquitination after HSP27 downregulation
was tenuous instead, ubiquitin-independent proteasomal
degradation of Daxx was observed. Here, we provide
evidence of distinctly different mechanisms of Daxx reg-
ulation at both the transcriptional and posttranslational
levels in human and mouse cancer cells. First, we
demonstrated that cellular levels of Daxx are the main
limiting factor for oncolytic adenoviral replication irre-
spective of the presence of E1B55K or wild-type p53 in
murine cells. We also demonstrated that the induction of
HSP25 increases oncolytic adenoviral replication in
mouse cancer cells via Daxx downregulation and that
Daxx expression is tightly regulated by the actions of both
HSP25 and stat3 in mouse cancer cells. HSP25 also likely
functions as a p53 suppressor that renders cells capable of
efﬁcient viral replication in mice22, similar to the effects of
viral E1B55K in both human and mouse cells. Here, we
found that HSP27 expression was strongly correlated with
Daxx expression in human cancer cells and that enhanced
viral replication was induced by HSP27 downregulation
depending on the cellular p53 status; thus, HSP27 and
HSP25 perform distinctly different roles in human and
murine cancer cells (Supplementary Fig. 3, Figs. 2d, e, 3d).
These differences also arise from the differential locali-
zation of these two homologs in the nucleus and cyto-
plasm. Furthermore, different mechanisms governed
Daxx degradation in human and mouse cancer cells:
human Daxx degradation induced by HSP27 down-
regulation was mainly the result of ubiquitin-independent
proteasomal degradation; on the other hand, Daxx in BNL
cells expressing HSP25 was not degraded by the protea-
some, suggesting that mouse Daxx resists proteasomal
degradation. Unlike the HSP27-Daxx regulatory system in
human cells, HSP25-mediated regulation of Daxx
expression in mouse cells appeared to occur via regulation
of the nuclear translocation of stat3, a transcription factor
that induces Daxx expression. This ﬁnding suggests that
the HSP25–stat3 interaction controls Daxx expression at
mainly the transcriptional level, whereas a more complex
mechanism involving both the HSP27-mediated regula-
tion of Daxx proteasomal degradation and the stat3-
dependent induction of Daxx transcription controls cel-
lular Daxx levels in human cells.
(see ﬁgure on previous page)
Fig. 5 Stat3 binding to HSP27 or HSP25 positively regulates Daxx expression. a Human A375 and MIaPaCa-2 cells and mouse BNL-HSP25 and
B16BL6-HSP25 cells were lysed and subjected to immunoprecipitation with anti-HSP27 (left) or anti-HSP25 antibodies (right) to detect the interaction
between HSP27 (HSP25) and stat3. b Daxx promoter binding was analyzed by ChIp assays using antibody against stat3. BNL and BNL-HSP25 mouse
cancer cells and A375 and MiaPaCa-2 human cancer cells infected with adenovirus (NC or shRNA against HSP27) at an MOI of 100 were used to
immunoprecipitate stat3 to determine the effect of HSP25 or HSP27 on Daxx promoter binding. Error bars represent standard errors from three
independent experiments. c The distribution of stat3 was examined using confocal immunoﬂuorescence. Cellular stat3 was detected with species-
speciﬁc primary anti-stat3 antibody conjugated to Flamma 552. d The cytoplasmic/nuclear localization of stat3 in a BNL mouse cell line with or
without HSP25 was determined by cytoplasmic and nuclear fractionation followed by detection using cytoplasmic (actin) and nuclear (histone H1)
marker proteins, respectively (left). Cytoplasmic/nuclear localization of stat3 in human cell lines after their infection with adenovirus (NC or shRNA
against HSP27) at an MOI of 100 was determined by cytoplasmic and nuclear fractionation followed by detection using cytoplasmic (actin) and
nuclear (histone H1) marker proteins, respectively (right)
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Fig. 6 HSP25 structural domain responsible for stat3 mobilization to nucleus. a Cellular Daxx levels were examined by the transfection of siRNA
against stat3 into A375 and MiaPaCa-2 human cancer cells (left) and BNL and BNL-HSP25 mouse cancer cells (right). b Amino acid sequence
alignment between human HSP27 and mouse HSP25 to identify the two most variable regions between HSP27 and HSP25 (domains I, II). These
regions in HSP27 were replaced with those from HSP25 domain to identify the HSP25 structural domain(s) responsible for impeding stat3
mobilization to the nucleus. c The distribution of HSP25 was examined using confocal immunoﬂuorescence. Cellular HSP25 was detected with
species-speciﬁc primary anti-HSP25 antibody conjugated to Alexa Fluor 594. Changes in the cytoplasmic/nuclear localization of HSP25 were
examined in the BNL mouse cell line after its transfection with pcDNA3.1-HSP25 as a control or pcDNA3.1-HSP25 with domains I, or II or both from
HSP27. d The cytoplasmic/nuclear localization of stat3 was examined in the BNL mouse cell line after its transfection with pcDNA3.1-HSP25 or
pcDNA3.1-HSP25 with domains I+ II of HSP27 following fractionation into cytoplasmic and nuclear fractions using cytoplasmic (tubulin α) and
nuclear (histone H1) marker proteins, respectively. e Cellular levels of stat3 were examined after transfection of the BNL cell line with HSP25, HSP25/27
domains I+ II, or HSP27. The numbers indicate the band intensities relative to that of BNL-pcDNA3.1 after the band intensities were measured with a
densitometer
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Fig. 7 Antitumor effects of oncolytic adenovirus expressing Daxx-speciﬁc shRNAs in MiaPaCa-2 or Panc02 tumors in mouse model
systems. a MiaPaCa-2 cancer cells were established in the abdominal walls of male BALB/c nude mice and injected with Ad-3484-NC as an oncolytic
negative control (NC) or Ad-3484-shhDaxx carrying oncolytic shhDaxx. Tumor growth was measured every 2 days for approximately 15 days until
necrotic cell death (upper). Error bars represent standard errors from ﬁve mice in each experimental group. After established tumors were infected
with oncolytic adenovirus expressing human Daxx-speciﬁc shRNA or oncolytic adenovirus expressing NC shRNA, tumor tissue sections were prepared
for immunohistochemical examination of Daxx expression (lower). b Panc02-myrAkt cancer cells were established in the abdominal walls of male
C57BL/6 mice and injected with Ad-3484-NC carrying oncolytic NC or Ad-3484-shmDaxx carrying oncolytic shmDaxx. Tumor growth was measured
every 2 days for approximately 15 days (upper). Error bars represent standard errors from ﬁve mice in each experimental group. After established
tumors were injected with oncolytic adenovirus expressing mouse Daxx-speciﬁc shRNA or oncolytic adenovirus expressing NC shRNA, tumor tissue
sections were prepared for the immunohistochemical examination of Daxx expression (lower; ×100magniﬁcation). The asterisk indicates a signiﬁcant
difference between the Ad-3484-NC and Ad-3484-shDaxx groups (P < 0.01)
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Taken together, these results suggest that oncolytic
adenovirus without E1B55K can replicate well in mouse
cells with even wild-type p53 when HSP25 is induced to
act as a cellular counterpart to E1B55K. In mouse cells,
two main proteins are involved in Daxx-related viral
replication: HSP25, which acts as a negative regulator, and
stat3, which acts as a positive regulator. During the sta-
tionary phase, HSP25 is rarely expressed in cells, allowing
stat3 to freely translocate into the nucleus, where it
functions as a transcription factor to induce Daxx
expression and consequently decrease adenoviral repli-
cation. Upon HSP25 induction, HSP25 sequesters stat3
and prevents it from moving into the nucleus, resulting in
a decrease in Daxx expression and a consequent increase
in adenoviral production. Regulation by the combination
of HSP25/stat3 is fairly simple in mouse cells, with HSP25
acting as a negative regulator of Daxx and stat3 acting as a
positive regulator of Daxx.
In conclusion, our study reveals that high levels of Daxx
due to the decreased expression of HSP25 in mouse cells
result in inefﬁcient adenoviral replication. Furthermore,
Daxx downregulation is likely to play a crucial role in
adenoviral replication; thus, Daxx downregulation may
proffer a viable approach to enhancing oncolysis by
oncolytic adenoviruses both with and without E1B55K,












































































Fig. 8 Schematic diagram of the molecular mechanism by which cellular Daxx is differentially regulated in humans and mice. Mouse Daxx
is primarily regulated at the transcriptional level via HSP25-induced inhibition of stat3 translocation to the nucleus. In contrast, human HSP27
positively affects stat3 activity to increase human Daxx transcriptional expression. In addition, human Daxx, but not mouse Daxx, is degraded by
ubiquitin-dependent lysosomal degradation, while HSP27 downregulation-induced Daxx degradation proceeds through ubiquitin-independent
proteasomal degradation
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schematic diagram showing cellular Daxx regulation in
human and mouse cells. A better understanding of the
molecular mechanisms underlying the regulation of Daxx
by human HSP27 or mouse HSP25 contributes to the ﬁeld
of viral gene therapy by ﬁlling a vital knowledge gap on
differential adenoviral replication in cells of human or
mouse origin.
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